Whole Exome Sequencing WES Test Cost AED:5200.0
At DNA Labs UAE, we offer the Whole Exome Sequencing (WES) test at a cost of AED 5200.0. This test is designed to analyze the coding regions of a person’s DNA, known as the exome, and identify genetic variants associated with a person’s disease or condition.
Test Name: Whole Exome Sequencing WES Test
Components: Covers 23000 genes associated with known clinical phenotypes
Price: 5200.0 AED
Sample Condition: Blood
Report Delivery: 4 weeks
Method: NGS DNA Sequencing
Test Type: Genetics
Doctor: Physician
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information
WES provides the right balance of insights and price. Whole Genome Sequencing (WGS) takes too long, is often cost-prohibitive, and the data needed is usually in the exonic regions. Sanger sequencing and microarray are not cost-effective for large target regions. Targeted pre-defined panels often don’t contain all of the data needed for the project.
Test Details
Whole Exome Sequencing (WES) is a genetic test that analyzes the coding regions of a person’s DNA, known as the exome. The exome contains the genes that are responsible for producing proteins, which are the building blocks of the body. WES is a powerful tool for identifying genetic variants that may be associated with a person’s disease or condition.
During the WES test, a sample of a person’s DNA is extracted and purified. The exome is then captured using a technique called hybridization capture, which selectively binds and isolates the exome from the rest of the DNA. The captured exome is then sequenced using next-generation sequencing (NGS) technology, which reads the DNA sequence of the exome.
The resulting data is analyzed by bioinformaticians to identify genetic variants that may be associated with the person’s condition. These variants are compared to known databases of genetic variants to determine their significance. The results of the WES test can help diagnose genetic disorders, predict the risk of developing certain conditions, and guide treatment decisions.
Availability and Insurance Coverage
WES is a relatively new technology and is still being refined and improved. It is not yet available to everyone, and insurance coverage for the test may vary. However, as the technology continues to improve and become more widely available, WES has the potential to revolutionize the diagnosis and treatment of genetic diseases.
Test Name | Whole Exome Sequencing WES Test |
---|---|
Components | Covers 23000 genes associated with known clinical phenotypes |
Price | 5200.0 AED |
Sample Condition | Blood |
Report Delivery | 4 weeks |
Method | NGS DNA Sequencing |
Test type | Genetics |
Doctor | Physician |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | WES provides the right balance of insights and price Whole Genome Sequencing (WGS) takes too long, is often cost-prohibitive, and the data needed is usually in the exonic regions Sanger sequencing and microarray are not cost-effective for large target regions Targeted pre-defined panels often dont contain all of the data needed for the project |
Test Details | Whole Exome Sequencing (WES) is a genetic test that analyzes the coding regions of a person’s DNA, known as the exome. The exome contains the genes that are responsible for producing proteins, which are the building blocks of the body. WES is a powerful tool for identifying genetic variants that may be associated with a person’s disease or condition.
During the WES test, a sample of a person’s DNA is extracted and purified. The exome is then captured using a technique called hybridization capture, which selectively binds and isolates the exome from the rest of the DNA. The captured exome is then sequenced using next-generation sequencing (NGS) technology, which reads the DNA sequence of the exome.
The resulting data is analyzed by bioinformaticians to identify genetic variants that may be associated with the person’s condition. These variants are compared to known databases of genetic variants to determine their significance. The results of the WES test can help diagnose genetic disorders, predict the risk of developing certain conditions, and guide treatment decisions.
WES is a relatively new technology and is still being refined and improved. It is not yet available to everyone, and insurance coverage for the test may vary. However, as the technology continues to improve and become more widely available, WES has the potential to revolutionize the diagnosis and treatment of genetic diseases. |